Information Library
Results for: White Papers - Faster product development
To learn more about Quintiles’ services, you may broaden or narrow your search by selecting the topics at left.
- Sort by:
- Recently Added
- Title
-
The Molecular Biomarker Revolution in Non-Small Cell Lung Cancer
June 23, 2011
In this new white paper Quintiles’ experts Christopher Ung, Jason Hill, Carrie Lee and Harish Dave review some of the most promising molecular pathways and targeted approaches for NSCLC, the critical role of diagnostics, and strategies to detect and address the emergence of resistance. -
Asia
March 8, 2011
This paper examines new development models as Western companies seek to develop and register their products in Asia, while emerging Asian companies seek new capabilities to globalize products. -
Oncology Drug Development and Value-Based Medicine
November 5, 2010
This report demonstrates the need to converge clinical and commercial imperatives earlier within the drug development process to meet a future demand for value-based medical practices. -
Pharmacobiomics and Infectious Disease: Progress and Opportunities
November 2, 2010
Pharmacobiomics and Infectious Disease: Progress Opportunities. After decades of work mapping the human genome, we are beginning to reap real benefits. -
From Biomarkers to Diagnostics - The Road to Success
October 18, 2010
In the second installment of a two-part series, Eric Groves, Jason Hill and Christopher Ung walk through the challenges associated with drug-diagnostic co-development, addressing potential pitfalls and areas of opportunity. -
Advancing Clinical Research in Alzheimer's Disease
October 18, 2010
This report from Quintiles’ own Alzheimer’s experts gives you an inside look at the news from ICAD 2010. -
Is a REMS Request from FDA More Likely for Drugs & Biologics Indicated for Pediatric Use?
October 8, 2010
Is a REMS Request From FDA More Likely For Drugs and Biologics Indicated for Pediatric Use? -
Using Real-Time Data to Drive Better Decisions, Faster
September 30, 2010
This white paper examines the advantages afforded by access to real-time data during the course of a clinical trial. -
Advancing Oncology Care Through Innovative Treatment Approaches
September 22, 2010
In this new white paper, Quintiles’ oncology experts Harish Dave and Eric Groves summarize the new findings and promising results presented at the June ASCO 2010 meeting. -
Navigating Future Challenges in Alzheimer's Disease Trials
September 21, 2010
Quintiles’ own Alzheimer’s experts, Amir Kalali, Roza Hayduk and Lynne Hughes, sum up the insights and discoveries that could lead to the next breakthrough for Alzheimer’s disease.
